MERITAGE PORTFOLIO MANAGEMENT – Corcept Therapeutics Incorporated Transaction History
MERITAGE PORTFOLIO MANAGEMENT portfolio value:
$489,000
portfolio value
MERITAGE PORTFOLIO MANAGEMENT quarter portfolio value change:
+7.82%
quarter
Corcept Therapeutics Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +3.44% | 633 shares | 51K | $25.64 | 19.05K |
| Q2 2022 | share | Decrease | -2.42% | -456 shares | 13K | $23.78 | 18.42K |
| Q1 2022 | share | Increase | +79.79% | 8.37K shares | 217K | $22.52 | 18.87K |
| Q4 2021 | share | Increase | 0.00% | 10.5K shares | 208K | $19.48 | 10.5K |